All times are listed in CEST (Central European Summer Time)

Special session Club A Club A

LuCE session 1 (ID 60)

Date
Fri, 01.04.2022
Time
12:45 - 14:15
Location
Club A
South Hall 2 Fri, 01.04.2022 18:45 - 20:15

MSD - Evolving immuno-oncology treatment paradigm in NSCLC (ID 55)

Time
18:45 - 20:15
Location
South Hall 2
Date
Fri, 01.04.2022
Proffered Paper session Forum Hall Forum Hall

Proffered Paper session 1 (ID 43)

Date
Wed, 30.03.2022
Time
16:30 - 18:00
Location
Forum Hall
South Hall 2 Thu, 31.03.2022 13:30 - 15:00

AstraZeneca - CNS disease management in EGFRm NSCLC (ID 38)

Time
13:30 - 15:00
Location
South Hall 2
Date
Thu, 31.03.2022
Young oncologists session South Hall 2 South Hall 2

YO session 2 (ID 57)

Date
Fri, 01.04.2022
Time
08:15 - 09:15
Location
South Hall 2
Mini Oral session South Hall 2 South Hall 2

Mini Oral session 1 (ID 45)

Date
Thu, 31.03.2022
Time
17:00 - 18:00
Location
South Hall 2
South Hall 2 Thu, 31.03.2022 18:15 - 19:45

Thermo Fisher Scientific (ID 40)

Time
18:15 - 19:45
Location
South Hall 2
Date
Thu, 31.03.2022
Special session Club A Club A

EONS session 2 (ID 59)

Date
Fri, 01.04.2022
Time
10:30 - 12:00
Location
Club A
Forum Hall Fri, 01.04.2022 18:45 - 20:15

Sanofi Genzyme - Quantity versus quality of life in advanced NSCLC patients treated with immunotherapy (ID 54)

Time
18:45 - 20:15
Location
Forum Hall
Date
Fri, 01.04.2022
Forum Hall Thu, 31.03.2022 13:30 - 15:00

Janssen Oncology - Evolving treatment options and practices in EGFR-mutant NSCLC (ID 37)

Time
13:30 - 15:00
Location
Forum Hall
Date
Thu, 31.03.2022
Special session Club A Club A

LuCE session 2 (ID 61)

Date
Fri, 01.04.2022
Time
15:10 - 16:40
Location
Club A
Young oncologists session South Hall 2 South Hall 2

YO session 1 (ID 56)

Date
Thu, 31.03.2022
Time
08:00 - 09:00
Location
South Hall 2